Company Novartis Pharmaceuticals S.r.l. with Fiscal Code 7608294
recorded a turnover of 2024 of
33.476.358,
with a net profit of
1.912.126
and having an average number of employees of
357.
The company operates in the field of Fabricarea produselor farmaceutice de bază having the NACE code 2110.
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded.
In the last year of activity, the sales decreased by -59.8%, from 83.797.774 euro in the year 2023, to 33.476.358 euro in 2024.
The Net Profit decreased by -1.970.073 euro, from 3.904.017 euro in 2023, to 1.912.126 in the last year.
Check all the financial reports of the company and know the risks in collaboration with it.
Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
110.519.225 euro in 2024 which includes Inventories of
6.816.161 euro, Receivables of
91.580.126 euro and cash availability of
12.122.937 euro.
The company's Equity was valued at
47.901.290 euro, while total Liabilities amounted to
93.110.337 euro.
Equity increased by 1.933.994 euro, from 46.225.638 euro in 2023, to 47.901.290 in 2024.
Similar services useful for checking companies and business development.
SellNet
Get the contact details for any company and get in touch with it.
Sectoral Studies
Knows the market and develops its own development strategies according to sectorial data.
Databases
Export in excel files the data of the companies selected according to the desired criteria.
Import - Export
Find importers and exporters according to the type of activity and the countries in which they carry it out.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Novartis Pharmaceuticals S.r.l.